Platelet-rich plasma (PRP) · Lesson 23 of 25 · 3 min

Is PRP covered by insurance? Coverage and regulatory basics

Most PRP is self-pay. This guide outlines insurance coverage, the FDA framework, facility rules and what clinicians need in place before offering PRP.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • Medicare generally treats PRP as investigational or not medically necessary for most indications.
  • Commercial coverage varies by payer, plan and indication, and aesthetic uses are not covered.
  • Autologous, minimally manipulated PRP does not require FDA premarket approval. Its applications are off-label.
  • Adding drugs, hormones or growth factors to PRP is prohibited without an Investigational New Drug approval.
  • Facilities handling blood must meet the OSHA Bloodborne Pathogens Standard.
  • Consent should cover the evidence status of the specific use and the self-pay cost.

Insurance coverage

Most PRP treatment is paid for by the patient. Medicare generally considers PRP investigational, experimental or not medically necessary for most indications. As of 2024 this included osteoarthritis, tendinopathies and aesthetic uses.

Medicare may cover PRP in limited settings, such as certain wound care uses with extensive documentation or within approved clinical trials. Commercial coverage varies by payer, plan and indication. Aesthetic uses are treated as cosmetic and are not covered.

The FDA framework

PRP prepared from a patient's own blood, with minimal manipulation and for homologous use, does not require FDA premarket approval. Homologous use means a use related to the normal function of platelets. PRP applications are considered off-label.

Some practices are prohibited without an Investigational New Drug (IND) approval. These include adding outside growth factors, hormones or drugs to PRP. Culture expansion or more than minimal manipulation of platelets is also prohibited.

Facility and compliance requirements

Any facility performing PRP must comply with the OSHA Bloodborne Pathogens Standard. This requires a written exposure control plan.

Whether laboratory rules known as CLIA apply to PRP preparation is unsettled and depends on the jurisdiction. The course advises checking with the state medical board and legal counsel.

Training, quality and consent

Training programs are typically open to physicians, dentists, physician assistants and nurse practitioners. Registered nurses may be eligible depending on state rules. A valid license and authority to perform injections within scope of practice are required.

Commercial PRP systems differ widely in performance, cost and processing time. Periodic checks of platelet concentration confirm that a system and its operator are producing a consistent product.

Informed consent should describe the procedure and the evidence status of the specific use. It should also cover the cost, since most patients pay out of pocket.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Comparing commercial PRP systems
  • Cost planning and pricing
  • Billing codes and claim appeals
  • Quality checks on platelet concentration
  • Consent documents and clinic workflow

Common questions.

Does Medicare cover PRP injections?
Generally no. Medicare considers PRP investigational or not medically necessary for most indications, with limited exceptions such as certain wound care uses or approved clinical trials.
Is PRP regulated by the FDA?
Autologous, minimally manipulated PRP for homologous use does not require FDA premarket approval. It is not FDA-approved for specific indications, and PRP applications are considered off-label.
Who can perform PRP procedures?
Training is typically open to licensed physicians, dentists, physician assistants and nurse practitioners, and to registered nurses where state rules allow. Injections must fall within the clinician's scope of practice.

Sources

  • Fitzpatrick J, et al. A review of commercially available point-of-care devices to concentrate platelet-rich plasma. J Orthop Surg Res. 2022;17(1):444.
  • Centers for Medicare & Medicaid Services. National Coverage Determination (NCD) for Platelet Rich Plasma (PRP). CMS Manual System. 2024.
  • American Medical Association. Current Procedural Terminology (CPT) 2024 Professional Edition. Chicago: AMA Press; 2023.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.